Borderline Personality Disorder Features and Risk for Prescription Opioid Use Disorders
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Although there is evidence for high comorbidity between borderline personality disorder (BPD) and substance use disorders, particularly alcohol use, more research is needed on the associations between BPD and prescription opioid use because of the increasing national problem of prescription opioid misuse. The purpose of the present study was to examine relationships between BPD features and prescription opioid use, risk for misuse, consequences, and dependence features, and to determine which aspects of BPD account for these associations. As predicted, BPD features were associated with greater quantity and frequency of opioid use, risk for pain medication misuse, consequences, and dependence features. Additional analyses indicated that most of these effects were accounted for by the self-harm/impulsivity component of BPD. The authors conclude that individuals with more pronounced BPD features may be at risk for use and dependence on prescription opioids, and that this association may be primarily associated with the impulsivity features of BPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grant, B. F., Chou, S. P., Goldstein, R. B., Huang, B., Stinson, F. S., Saha, T. D., Smith, S. M., Dawson, D. S., Pulay, A. J., Pickering, R. P., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0404 · Cited by 1,618
The borderline diagnosis I: psychopathology, comorbidity, and personaltity structure
Skodol, A. E., Gunderson, J. G., Pfohl, B., Widiger, T. A., Livesley, W. J., & Siever, L. J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01324-0 · Cited by 769
Borderline personality disorder and substance use disorders A review and integration
Trull, T. (2000) · Clinical Psychology Review · doi:10.1016/s0272-7358(99)00028-8 · Cited by 520
Validation of the Revised Screener and Opioid Assessment for Patients With Pain (SOAPP-R)
Butler, S. F., Fernandez, K., Benoit, C., Budman, S. H., & Jamison, R. N. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.11.014 · Cited by 471
Whiteside, S. P., & Lynam, D. R. (2003) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.11.3.210 · Cited by 463
Medical and Nonmedical Use of Prescription Opioids Among High School Seniors in the United States
McCabe, S. E. (2012) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2012.85 · Cited by 158
Bohus, M. J., Landwehrmeyer, G. B., Stiglmayr, C. E., Limberger, M. F., Böhme, R., & Schmahl, C. G. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0906 · Cited by 153
Borderline personality disorder: a dysregulation of the endogenous opioid system?
Bandelow, B., Schmahl, C., Falkai, P., & Wedekind, D. (2010) · Psychological Review · doi:10.1037/a0018095 · Cited by 135 · cited 2×
“, 2000, 2010), and perspectives on BPD emphasizing dysregulation of the endogenous opioid system (Bandelow et al., 2010; Prossin et al., 2010; Stanley & Siever, 2010).”
BackgroundEvaluation of naltrexone for dissociative symptoms in borderline personality disorder
Schmahl, C., Kleindienst, N., Limberger, M., Ludäscher, P., Mauchnik, J., Deibler, P., Brünen, S., Hiemke, C., Lieb, K., Herpertz, S., et al. (2012) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32834d0e50 · Cited by 63 · cited 1×
“, 2010), evidence for the effectiveness of the opioid antagonist naltrexone in the treatment of dissociative symptoms in BPD (Bohus et al., 1999; Schmahl et al., 2012), and evidence for higher pain thresholds among individuals with BPD and a history of self-harm (Cárdenas-Morales et al.”
Background
Cited by
Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10386 · Cited by 222
Martel, M. O., Edwards, R. R., & Jamison, R. N. (2020) · American Psychologist · doi:10.1037/amp0000632 · Cited by 43
Johnson, B. N., Lumley, M. A., Cheavens, J. S., & McKernan, L. C. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110164 · Cited by 32
“In those with chronic pain, the presence of BPD is associated with increased pain symptoms (12-18), pain-related interference (12,18), and somatic and psychological symptoms (4,17,19), and a decreased likelihood of pain remission (20).”
Background
Metadata
- Authors
- Tragesser, S. L., Jones, R. E., Robinson, R. J., Stutler, A., & Stewart, A.
- Venue
- Journal of Personality Disorders
- Publisher
- Guilford Publications
- Published
- 2013-08
- Volume
- 27
- Issue
- 4
- Pages
- 427-441
- ISSN
- 0885-579X (ISSN-L)
- OpenAlex
- W2129888860
- Cited by
- 41
- References
- 9
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Borderline Personality Disorder Features and Risk for Prescription Opioid Use Disorders. https://app.cochat.ai/papers/10.1521/pedi_2013_27_094
- The paper
- Tragesser, S. L., Jones, R. E., Robinson, R. J., Stutler, A., & Stewart, A. (2013). Borderline Personality Disorder Features and Risk for Prescription Opioid Use Disorders. Journal of Personality Disorders. https://doi.org/10.1521/pedi_2013_27_094
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.